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ABSTRACT 
Gold based nanoparticles, owing to their unique optical properties at the nanoscale, biocompatibility, and rich surface chemistry, have attracted 
considerable attention from the material science and biomedical community. Although colloidal gold has been used since ancient times in various 
therapeutic applications, a better understanding of the physical attributes of nanosized gold has led to a burst of research activity in the past twenty 
years related to their synthesis and biomedical applications. Novel strategies for the synthesis of nanosized gold of various shapes and 
morphologies have been put forward, which includes nanospheres, nanorods, nanocages, nanoshells, etc. Both the absorption and scattering 
properties of nanosized gold, along with their facile conjugation with different biomolecules, has been exploited in the development of a number of 
bioanalytical assays and protocols, related to the quantification of nucleic acids, proteins, other small biomolecules, etc. In addition, gold 
nanoparticles are being increasingly used for in vivo imaging applications for the early diagnosis of cancer. Finally, gold nanoparticles are playing a 
significant role in nanotherapeutic applications, either as drug carriers or as the drug itself in light-activated photothermal therapy. Several gold-
nanoparticle based Bioanalytical assays and therapeutic applications are in the active clinical development phase. This chapter will provide 
examples of the various biomedical applications of gold nanoparticles with potential for clinical translation. 
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INTRODUCTION 
In the realm of nanotechnology and nanomedicine, gold nano-
structures are undoubtedly the most extensively investigated ones 
owing to their versatility [1-4]. This versatility stems from a number 
of beneficial characteristics that gold possesses in the nano-
dimension. These include their unique optical, electronic and 
catalytic properties, biocompatibility, non-immunogenicity, 
antimicrobial properties, and facile surface chemistry. Colloidal gold 
has been used since ancient times as a coloring material owing to 
their vibrant, size and concentration-dependent multiple colors 
(yellow, ruby red, orange, maroon, etc), with the glass decoration in 
churches being a prominent example. Colloidal gold was also used 
extensively in ancient times for medicinal applications, such as the 
‘elixir’ drink used in ancient Egypt as what was believed to bea 
‘rejuvenative potion’, powdered gold mixed with drinks for the 
treatment of sore limbs (arthritis) in medieval Europe, for the 
treatment of alcoholism and other addictions in nineteenth-century 
United States, etc. In modern times, with the growing awareness of 
the importance of nanotechnology in medicine and healthcare, the 
applications of gold nanoparticles have increased exponentially, 
from the analysis of body fluids and cells for the identification of 
biochemical signatures indicative of diseases to the diagnosis and 
targeted treatment of cancer. In general, nanoparticulate gold has 
both diagnostic and therapeutic capabilities, two beneficial features 
that scientists are currently trying to merge together into what is 
known as ‘theranostic’ medicine [5, 6].  
This book chapter will first briefly explain the physical principles 
underlying the unique properties of nanosized gold, followed by 
their various applications in medicine, with emphasis on their 
potential for clinical translation. Owing to the vast literature 
available on the topic of various biomedical applications of 
nanosized gold, only selected examples have been provided here; 
the authors sincerely regret any unintentional exclusion. The 
authors have also referred to informative review articles and book 
chapters available on several sub-topics at suitable sections within 
this chapter. The various synthetic methodologies developed for the 
synthesis of a myriad of gold nanostructures, such as nanospheres, 
nanorods, nanoshells, nanocages, etc are not discussed in this 
chapter; readers are suggested to consult some excellent reviews 
available on this topic [7, 8].  
Physical features 
Several inorganic materials such as gold, some semiconductors, iron 
oxide, etc. are known to possess certain unique physical properties 
when their dimensions are reduced to the nanoscale. These physical 
properties, which are absent in their respective bulk counterparts, 
emanates from the principle of quantum confinement, which means 
their size is confined within the quantum domain [9, 10]. For 
nanosized gold, the unique properties are electronic and optical, the 
latter receiving more attention owing to their widespread 
applications in both non-biological and biological disciplines [11]. 
The bright, tunable color of colloidal gold stems directly from this 
optical property, which is known as the localized surface plasmon 
resonance (LSPR) effect. Here, upon irradiation with light, the 
conduction band electrons in nanosized gold begins to oscillate 
coherently with a frequency that lies in the visible to near infra-red 
(NIR) region of the electromagnetic spectrum [12, 13]. This results 
in light absorption by colloidal dispersions of nanosized gold, with 
the LSPR absorption peak within the visible to NIR range.  
This LSPR absorption peak is also tunable within this range, which 
depends on a number of factors, such as particle size, shape, 
aggregation/de-aggregation, surface characteristics, and the 
refractive index of the surrounding medium [14, 15]. Typically, this 
peak for spherical gold colloids (approximate diameter 5-15 nm) 
varies close to 520 nm. However, upon changing the shape to rod-
shaped ones, two distinct peaks arise, with the transverse peak 
(accounting for the cross-sectional diameter of the rods) around 
520-530 nm, and the longitudinal peak (accounting for the length of 
the rods) towards red and NIR regions (within 600 to 1200 nm) 
[16]. Therefore, by varying the aspect ratio (length/diameter) of the 
rods, gold nanorods with multiple transverse and longitudinal peaks 
can be prepared, which will have immense applications in 
multiplexed diagnostics.  
There are several other features of nanosized gold particles which 
can be exploited in imaging and diagnosis of biological samples. For 
example, the high electron density and light scattering associated 
with gold nanoparticles make them useful contrast agents in live 
cells using electron microscopic and dark-field imaging, respectively. 
Gold nanoparticles can also be used for signal enhancement of small, 
Raman-active molecules for surface-enhanced Raman scattering 
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(SERS)-based detection. In the realm of in vivo imaging gold 
nanoparticles have potential applications in two-photon optical, 
optical coherence tomographic (OCT) and photoacoustic 
tomographic imaging, etc. Finally, owing to their ability to convert 
optical absorption into heat energy via nonradiative electron 
relaxation dynamics, gold nanoparticles are presently being used for 
photothermal therapy of cancer in vivo and as drug carriers for 
targeted drug delivery.  
Biomedical applications of gold nanoparticles 
Nanosized gold has potential applications in every sphere of 
medicine, whether it is in the identification of unique biochemical 
signature of a disease or a diseased cell circulating in the blood, or in 
the immunization of an individual as a safeguard against invasion by 
a pathogen such as a virus, or in the early diagnosis and treatment of 
cancer. Simply put, these applications can be broken down into 
diagnostics, prophylaxis, therapeutics, and theranostics. Among 
them, in vitro bioanalytical techniques such as biosensing have 
better potential for clinical translation as here the nanoparticles are 
not introduced in the body, and hence, concerns about their in vivo 
toxicity and long-term persistence in the body are absent. In 
addition, despite these potential toxicity concerns, gold 
nanoparticles are showing considerable promise in therapeutics 
such as photothermal therapy and siRNA therapy, with a few 
products being in the active clinical pipeline. A number of such 
applications are presented in the following few sections.  
Analytical and diagnostic techniques 
As stated earlier, the unique optical properties of nanosized gold has 
been extensively exploited in developing numerous assays for the 
detection of a myriad of biomolecules in vitro, such as nucleic acids 
(DNA, RNA, other oligonucleotides), proteins, peptides, lipids, other 
small biomolecules. These assays are colorimetric, electronic, 
scanometric, and Raman-based detection strategies, some of which 
have recently been commercialized and approved by the American 
Food and Drug Administration [17]. Such detection has significant 
implications in the early diagnosis of diseases, environmental 
monitoring for the presence of pathogens and harmful chemicals, 
genetic or proteomic profiling of biospecimens and organisms, etc. 
In addition to these in vitro diagnostic assays, gold nanoparticles are 
also being used for in vivo diagnosis, particularly towards the 
advanced detection of cancer. These diagnostic techniques are 
summarized below, with representative examples.  
Colorimetric biosensing 
Colorimetric assays take advantage of analyte-induced aggregation 
events that result in measurable changes and shifts of nanoparticle 
surface plasmon absorption bands. One of the earliest examples of 
gold nanoparticle-based colorimetric detection of specific nucleic 
acid sequences was provided in the laboratory of Chad Mirkin in 
1996. Here, using 13-nm gold particles tagged with a 
complementary polynucleotide sequence, it was shown that the 
color of the solution changed from red to blue upon analyte-directed 
aggregation in the presence of only the target polynucleotide 
sequence [18]. This color change is a consequence of interacting 
LSPRs and aggregate scattering properties. The introduction of 
nanoparticles into some well-studied DNA assays results in 
improved sensitivity. For example, surface plasmon resonance (SPR) 
is used to detect and probe real-time DNA hybridization surfaces 
with detection limits of 150 nM target [19]. 
Rapidly increasing demand of disease diagnostics is significant due 
to the fast and accurate detection of DNA. In this study detection of 
hepatitis B virus (HBV) DNA hybridization was carried out in 
homogenous solution. This is a highly specific electrochemical and 
ultrasensitive sensing technique in which magnetic nanoparticles 
(MNPs) were synthesized and further modified with β-CD. Herein to 
ensure the hybridization a stem-loop like DNA was used as a probe 
and was labeled with dabcyl at the 5′ -end and Au NPS at 3′ -end 
where former act as a guest and later as an electrochemical tag. 
Thus, initially, the DNA remains in a stem-loop configuration which 
prevents the docking with β-CD/MNP in solution due to steric 
repulsions. Further the stem-loop DNA Probe was dissociated in the 
presence of complementary target DNA and the formation of double-
stranded DNA (dsDNA) takes place because of hybridization. Then β-
CD/MNP was linked with ds DNA due to the host–guest recognition 
between β-CD and dabcyl. Thus, the electrochemical signals 
provided by Au nanoparticles could be sensitively transduced by 
these hybridization events. Then an external magnetic field has 
been applied to capture the Au NPs through electrode. Thus, the 
designed sensor is capable for discrimination between the single-
nucleotide polymorphism (SNP)-containing sequences and healthy 
sequences [20]. 
Gold nanoparticle-based colorimetric biosensing has also been used 
for the detection of proteins and peptides, relying on the specific 
interactions between nanoparticle-bound antibodies with the target 
protein [21]. Halas and co-workers have used antibodies conjugated 
to the surface of gold nanoshells to detect proteins in saline, serum, 
and whole blood [22]. Upon interaction with the target protein, the 
antibody functionalized nanoshells aggregate, resulting in a 
corresponding broadening of the nanoshell extinction peak at 720 
nm. More information on colorimetric biosensing using gold 
nanostructures is available in several excellent reviews [2-23].  
Molecular beacons 
Another technique of detection of nucleic acids is using molecular 
beacons, which relies on the interaction of a fluorescent probe with 
a quencher. Gold nanoparticles have been extensively used as 
quenchers since here the quenching is much more efficient than 
molecular quenchers, resulting in a more sensitive probe [24]. In an 
interesting example, Nie and co-workers have designed a molecular 
beacon with oligonucleotides functionalized on one end with gold 
nanoparticles and the other end with a molecular fluorophore. The 
‘loop’ structure is formed with the fluorophore nonspecifically 
binding to the gold surface, along with quenching of fluorescence. 
Upon binding to the ‘target’ oligonucleotide sequence the ‘loop’ 
breaks, resulting in separation of the fluorophore and the gold 
nanoparticle (quencher), leading to fluorescence signal [25]. In 
another study, to measure the trypsin in biological samples a selective 
fluorometric platform has been constructed with the help of Au-
peptide-FITC beacon. FITC, which is already a fluorophore, was 
quenched by gold nanoparticles owing to FRET mechanism and 
further it was recovered after selective cleaving of beacon peptide by 
trypsin. The concentration range of 10-100 nmol/l with a correlation 
coefficient and limit detection 0.995 and 5 nmol/l respectively was 
used for the calibration plot for trypsin. In addition trypsin in blood 
plasma can also be used by using present approach [26]. 
Photoluminescence 
There is a growing excitement in the use of plasmonic properties of 
nanosized good for enhancing the photophysical processes resulting 
in luminescence. The weak photoemission of gold can be enhanced 
by many orders of magnitude when coupled with an appropriate 
plasmon excitation [4]. A gold nanoparticle possesses both linear 
and non-linear (two-photon) photoluminescence, the later 
manifesting at pulsed laser excitation. The photoluminescence 
arising from nanosized gold has several advantages over that of 
organic dye-based fluorophores, which includes higher absorption 
cross-section and resistance to photo bleaching. Two-photon 
luminescence is particularly exciting as it enables excitation and 
emission at the near infra-red (NIR) window with maximum light 
permeability through biological tissues, emission far removed from 
the cellular/tissue auto fluorescence window, and requirement of 
low-power density during imaging thus ensuring minimum damage 
to biological specimens.  
Several reports exist in literature that has demonstrated the 
potential of nanosized gold particles in cellular (in vitro) and 
intravital (in vivo) luminescence imaging. For example, using two-
photon luminescence imaging, Tong et al. showed that gold 
nanorods conjugated with folic acid could be efficiently targeted to 
KB cells (which over express folic acid receptor), but not to NIH/3T3 
fibroblast cells (which does not overexpress folic acid receptor). The 
internalized gold nanorods exhibited high signal-to-noise 
luminescence, which also enabled single-particle tracking within the 
cells to study the intracellular nanoparticle-dynamics [25]. The in 
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vitro two-photon luminescence imaging using bioconjugated gold 
nanoparticles has also been extended to cell supported tissue-
phantoms. For example, anti-EGFR conjugated gold nanorods could 
be imaged with a penetration depth of 75 nm in epithelial tissue 
phantoms consisting of collagen-supported EGFR-overexpressing 
A431 skin cancer cells, with minimum damage to the tissue [27-29]. 
In another study a thin film of gold on a polyethene terephthalate 
substrate was induced by low energy Ar ion along with other 
thermodynamic interpretations and corresponding photo-
luminescence (PL) properties and specific surface plasmon response 
(SPR). These properties observed are associated due to the 
absorption of methyl orange (MO) dye molecules on the surface and 
its surface-enhanced Raman scattering (SERS) effect. The spherical 
nanoparticles formation take place due to the dwetting of the film 
because of sputtering and ion induced thermal spike. Further 
thermodynamic driving forces played a key role in embedding the 
nanoparticles in modified PET [30]. 
In vivo intravital two-photon luminescence imaging using gold, 
nanorods were first demonstrated by wang et al., who have 
monitored flow dynamics of CTAB-coated nanorods through the 
blood vessels in a mouse earlobe, following their tail vein injection 
[31]. The luminescence signals were three times higher than the 
background autofluorescence. However, the authors did not observe 
any signal 30 min after injection, indicating fast clearance of these 
nanorods from the blood. This blood-circulation time, however, 
could be significantly increased following coating these nanorods 
with a layer of polyethylene glycol (PEG) [32]. 
Optical coherence tomography (OCT) 
Optical coherence tomography (OCT) is an interferometric imaging 
modality where backscattered NIR light is detected. This technique 
is particularly promising for biomedical imaging applications 
because it provides noninvasive imaging of living tissues with 10–25 
times greater spatial resolution than that produced by ultrasound 
imaging and up to 100 times better than magnetic resonance 
imaging or computed tomography [4]. NIR-active contrast agents 
such as gold NRs can significantly enhance the OCT contrast based 
on modulations in optical absorption or scattering. Using 
polyacrylamide-based tissue phantoms, Troutman et al. have 
demonstrated OCT image distribution of gold nanorods with 
appropriate scattering and anisotropy coefficients , along with an 
estimated detection limit as low as 30 p. p. m. [33]. Furthermore, 
gold nanorod mediated OCT contrast enhancement has also been 
demonstrated in vivo in an excised sample of human breast invasive 
ductal carcinoma [34]. Recently, using a sensitive temperature 
variation of OCT, known as photothermal OCT (PT-OCT), the time-
dependent imaging and distribution of gold nanorods (GNRs) in the 
sentinel lymph node (SLN) of mice in vivo was shown [35]. 
Photoacoustic tomography (PT) 
Photoacoustic tomography (PAT) is a noninvasive imaging 
technique based on NIR-induced photoacoustic effects, with a depth 
penetration of several centimeters in biological tissues [4]. Owing to 
photoinduced cavitation effects produced by NIR-absorbing gold 
nanorods, they serve as excellent contrast agents in PT imaging. For 
example, gold nanorods significantly enhanced PT images in nude 
mice when subcutaneously injected in picomolar concentrations 
[35]. Gold nanorods have also been used as PT contrast agents for 
quantitative flow analysis in biological tissues [36]. Owing to their 
potential for in vivo imaging, gold nanoparticles as contrast agents 
for OCT and PT imaging are being actively investigated in various 
laboratories at present.  
Electron microscopic and dark field imaging 
In vitro imaging based investigations of cellular composition and 
processes can yield rich information about the nature, 
differentiation pattern and stimuli-sensitivity of various cells, such 
as immune cells, cancer cells, stem cells, etc. Fluorescence imaging 
based investigations have been extensively carried out in this 
regard, where organic dyes, and more recently bio conjugated 
quantum dots, have been used as the fluorescent probes. However, 
the photo bleaching tendency and wide emission bands of organic 
dyes, as well as the inherent toxicity and blinking associated with 
quantum dots, pose significant challenges towards successful 
fluorescence-based cellular imaging, particularly when prolonged 
imaging to probe a dynamic cellular process is in question.  
Optical scattering based imaging techniques such as darkfield imaging 
using bioconjugated gold nanoprobes can effectively remedy this issue 
as such probes are non-toxic and are resistant to photobleaching. 
Several groups have demonstrated the use of bioconjugated 
nanoparticles and nanorods in dark field imaging of cells and tissues, 
including dynamic molecular and macromolecular investigations 
within them [37-38]. Hu et al. have exploited the tunability of 
longitudinal plasmonic bands of gold nanorods to obtain wavelength-
selective plasmon-enhanced scattering from multicolored gold 
nanorods for targeted imaging of cancer cells. Moreover, they have 
demonstrated the combined dark field and electron microscopic 
imaging of cancer cells treated with bioconjugated gold and silver 
nanoparticles in a multiplexed manner [39].  
Surface-enhanced raman scattering (SERS) 
SERS is a promising surface-sensitive technique where scattering 
signal from Raman-active molecules are enhanced enormously, upto 
a factor of 10[15] when they are adsorbed on the surface of metallic 
nanoparticles. The exact mechanism of this enhancement is not yet 
clearly understood, with two parallel theories being put forward. 
The electromagnetic theory is based on the enhancement of electric 
field on the nanoparticle surface mediated by localized surface 
plasmons, whereas the chemical theory proposes the formation of 
charge-transfer complexes between the nanoparticle and the 
Raman-active molecules. Nevertheless, owing to the 
biocompatibility of metallic nanoparticles, SERS is fast gaining 
popularity as a bioanalytical technique capable of ultrasensitive 
detection of molecules to a single molecule level [40-41]. 
For example, Kneipp and coworkers used p-mercaptobenzoicacid 
(p-MBA)-conjugated Au nano aggregates for SERSimaging of pH in 
living NIH 3T3 cells [42]. Recently, Nie and coworkers have used 
malachite green as a Raman probe attached to gold nanoparticles, 
co-conjugated with an antibody specific to EGF receptors, to target 
and image EGF-receptor positive cancer cells in vitro and in vivo. As 
contrasted to non-targeted nanoparticle controls, the targeted 
nanoparticles were efficiently localized at the tumor site in vivo and 
detected by specific SERS bands of malachite green [43]. Several 
other examples of SERS-based Bioimaging using nanosized gold can 
be found in excellent reviews written on this subject [44-46]. 
Therapeutic applications of gold nanoparticles 
In addition to their various diagnostic and imaging capabilities as 
illustrated in the previous sections, owing to the biocompatibility 
and facile surface chemistry of nanosized gold, they have been used 
as carriers of therapeutic agents for targeted delivery to desired 
cells/tissues. These therapeutic agents can be traditional drugs such 
as doxorubicin and paclitaxel, or new generation therapeutics such 
as antisense and short-interfering (si) RNA. In addition, the unique 
light-to-heat conversion capability of gold nanoparticles is being 
increasingly exploited in the photothermal therapy (PTT) of cancer, 
with immense potential for clinical translation. Such applications are 
summarized below:  
Delivery of chemotherapeutics 
Among all the clinical cancer therapeutic treatments available till 
date, chemotherapy still looms large and gold nanoparticles have 
advanced into drug delivery applications because of its low inherent 
toxicity and rich surface chemistry. As opposed to ‘soft’ polymer-
nanoparticles where drugs are often simply encapsulated from 
where they release in a sustained manner, in ‘hard’ nanoparticles 
such as gold drugs are either chemically conjugated or 
electrostatically complexed on the surface. The surface chemistry of 
the gold nanoparticles plays an immense role in formulating an 
efficient drug delivery platform. Surface modification of the gold 
nanoparticles not only provides an increased circulation time and 
thus slows down the RES uptake, when modified with PEG 
molecules, but also can be easily targeted to the diseased site when 
coupled with specific biomolecules [47]. The therapeutic efficacy of 
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the drug usually depends on upon the method used for the drug 
delivery and thus the availability of the drug at the target site. The 
release of the drug from the nanoparticles can be modulated either 
by internal stimuli such as pH and enzymes, or external stimuli such 
as light [48-49].  
Non-covalent complexation of the drug with the gold nanoparticles 
provides a relatively simple platform in which drug can be 
incorporated with the gold nanoparticles without being chemically 
modified into a prodrug, or any other functional derivative. The use 
of appropriate ligands on the surface of gold nanoparticles provides 
the hydrophobic pockets where the hydrophobic drugs can be 
partitioned. Although non-covalent complexation of the drug with 
the gold nanoparticles can provide a relatively simple drug delivery 
platform, the covalent conjugation of the drug on the nanoparticles 
surface is far stronger and much stable [45]. However, the high 
stability of the covalent conjugation may result in an inefficient 
release of the drug at the target site [50]. Non-covalent complexation 
thus provides a slightly better platform for drug delivery using gold 
nanoparticles. Here, the surface of the gold nanoparticles can be 
modified with different polyelectrolytes such as poly (diallyl 
dimethyl ammonium chloride), poly (sodium-4 styrene sulfonate), 
poly (allylamine hydrochloride), which provides a net charge on the 
surfaces for non-covalent complexation with a countercharged 
therapeutic agent [51-52]. 
There have been a number of reports on the use of gold 
nanoparticles for drug delivery via non-covalent interactions. An 
example of drug delivery using PEG-modified gold nanoparticles is 
provided by Paciotti et al., who have used PEG-modified gold 
nanoparticles for delivery of the anti-cancer drug Paclitaxel [53]. 
They have shown that the 26 nm gold nanoparticles coated with a 
mixture of tumor necrosis factor and PEG-thiol can be targeted to 
the tumor cells by extravasation and provide an efficient delivery of 
paclitaxel. Tom et al. have shown that the release kinetics of 
ciprofloxacin functionalized gold nanoparticles is greatly influenced 
by the size of the functionalized nanoparticles and the type of 
release medium [54]. Rotello et al. have used 2.5 nm gold 
nanoparticles functionalized with a hydrophobic alkanethiol interior 
and a hydrophilic shell of tetra (ethylene glycol) for entrapping the 
drug into the hydrophobic monolayer [55]. 
Several reports on the covalent conjugation of the drug on the gold 
nanoparticle surface suggest a better efficiency of the drug in 
comparison to the same amount of free drugs. Chen et al. have 
reported a seven-fold increase in the efficiency of methotrexate 
conjugated to gold nanoparticles. The authors have conjugated the 
gold nanoparticles to the carboxylic group of the methotrexate and 
studied the cytotoxicity of the drug in the in vitro and in vivo Lewis 
lung carcinoma models [56]. In another report, PEG-coated gold 
nanoparticles were conjugated to TNF-α to maximize the tumor 
damage and minimize the systemic toxicity of TNF-α. The authors 
observed an enhanced therapeutic efficacy when gold nanoparticles 
conjugated TNF-α was injected intravenously in conjunction with local 
heating. This conjugate, now known as CYT-6091, is currently in Phase 
1 clinical trials for pharmacokinetic and clinical efficacy [57].  
To modulate the release kinetics of the covalently conjugated drug 
from the gold nanoparticles, several different approaches involving 
the use of an external stimulus have been explored. In one such 
report, Aryal et al. have conjugated the anti-cancer drug doxorubicin 
on the surface of the gold nanoparticles via a pH-sensitive 
hydrazone bond [58]. The acidic endosomal pH in the tumor cells 
resulted in the release of the doxorubicin from the gold 
nanoparticles, whereas at physiological pH the conjugate showed 
almost negligible release of the drug. Apart from pH, light has also 
been used as external stimuli for the conjugated drug release. 
Nakanishi et al. have reported photoresponsive gold nanoparticles 
conjugated histamine as a cell-signaling agent. The succinimidyl 
ester can be easily photocleaved using UV-irradiation [59]. Rotello et 
al. have used a photocleavable ligand to conjugate 5-fluorouracil 
with 2 nm gold nanoparticles [60]. The photocleavable ligand 
contains o-nitrobenzyl ester group which dissociates upon UV-light 
irradiation (365 nm) and releases the drug at the target site. Also, an 
enzyme (phosphodiesterases) based cleaving of the phosphate bond 
linking the anti-cancer drug paclitaxel to gold and iron oxide 
nanoparticles have been shown [61].  
Photodynamic therapy (PDT) 
PDT is a clinically approved and successful cancer therapy for 
various neoplastic and non-malignant diseases. In PDT, the 
therapeutic compounds known as photo sensitizers (PS) are 
activated with a specific wavelength of light, which results in a 
photochemical reaction leading to the generation of reactive oxygen 
species (ROS) such as free radicals and singlet oxygen (1O2) [10]. 
These species can rapidly cause significant toxicity leading to cell 
death via apoptosis or necrosis. The efficiency of PDT also depends 
on the concentration of PS accumulated in the target tissue and the 
associated wavelength of light used for excitation. Nanoparticles 
provide an important platform in increasing the efficiency of the 
PDT by delivering the PS to the target site, acting as energy 
transducers and as PS as such. There have been numerous 
approaches proposed for the selective delivery of the PS to the 
target site, which includes targeting the PS by conjugating to integrin 
antagonist/specific biomolecules, high payload PS delivery via 
various polymeric nanoparticles, liposomes, and micelles.  
Gold nanoparticles have been explored in the field of PDT for the 
delivery of PS’s like phthalocyanines to the target site [62]. The 
delivery of PS by using gold nanoparticles can be carried out either 
by covalent conjugation of the PS to the nanoparticle surface or by 
non-covalent complexation. The advantage of using gold 
nanoparticles relies on the fact that gold nanoparticles can easily be 
targeted to the diseased site by using specific biomarkers. Also, the 
surface of the gold nanoparticles can be easily modified with PEG 
molecules to avoid the opsonization process, which leads to the 
clearance of nanoparticles from the systemic circulation and 
accumulation in the liver and spleen. Stuchinskaya et al. have 
reported the use of a 4-component system of PS-gold nanoparticle 
conjugate for targeted in vitro PDT in breast cancer cells [63]. Burda 
and coworkers have shown non-covalent complexation of PEGylated 
gold nanoparticles with phthalocyanine 4 (Pc 4), a FDA-approved PS, 
as a delivery vehicle for the PS in a glioma cancer model [64]. The 
authors suggested that the non-covalent complexation of PS with 
nanoparticles provided fast and target-specific drug accumulation at 
the disease site, in comparison to free drug and covalent conjugate 
counterparts.  
Gene delivery 
Gold nanoparticles and nanorods, following appropriate surface 
modification, has been extensively employed for the delivery of 
oligonucleotide-based therapeutics such as antisense RNA, siRNA, 
microRNA, etc [65-66]. In the free form, these therapeutic RNA 
molecules have a very short half-life in physiological conditions, 
owing to their vulnerability for degradation by endogenous 
nucleases. Nanosized gold particles serve as macromolecular 
carriers that not only protect them from degradation in the 
biological milieu, but also steer them to desired cells/tissues and 
facilitate their cellular entry. Also, since the formation of the 
nanoparticle-oligonucleotide complex (the nanoplex) often involved, 
simple electrostatic interactions between conically-modified 
nanoparticle and the inherently anionic RNA molecules (owing to 
the presence of phosphate backbone), the chances of any chemical 
modification-mediated loss of functionality of the RNA molecule are 
negligible. Moreover, by exploiting the LSPR phenomenon 
associated with GNPs/GNRs, their complexation with genetic 
materials and subsequently their delivery and distribution within 
target tissues can be optically monitored [67]. 
Chad Mirkin’s group has extensively demonstrated the non-covalent 
or covalent binding of various RNA molecules to gold nanospheres, 
and their applications in nucleic acid detection assays, from within 
the cells and outside [17]. Recently, Paras Prasad’s group has 
demonstrated the use of gold nanorods electrostatically with 
therapeutic siRNA that plays a role in modulating the key 
components of the dopaminergic signaling pathway in brain cells in 
vitro, with efficiency greater than that of commercially available 
reagent (siPORT) [67]. As this pathway is implicated in opiate 
addiction, such nanotechnology mediated gene silencing strategies 
are expected to play a critical role in the treatment of drug addiction. 
The authors also showed that these nanoplexes displayed 
significantly higher transmigration efficiency across an in vitro 
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model of the blood-brain barrier (BBB) over that of free siRNA, 
without compromising the functional integrity of the barrier. 
Therefore, these nano plexes appear to be ideally suited for brain-
specific delivery of appropriate siRNA for therapy of drug addiction 
and other brain diseases. The same group also showed this 
technology to induce an immune response using single-stranded 
RNA (5′-PPP-ssRNA) molecules attached to gold nanorods in 
pulmonary cells [68]. 
Radiation therapy 
There has been a recent thrust in exploiting the physical properties 
of the gold nanoparticles to enhance the efficacy and specificity of 
radiation therapy. Clinical radiation therapy for cancer utilizes high 
energy (MeV) photons or electrons (by the external beam) or low 
energy (keV) photons (by internally place radioisotopes). Metal-
enhanced radiation therapy involves high atomic number (Z) 
materials like gold to increase absorption of low kilovoltage x-rays 
in the diseased site as compared to the normal tissue [69]. The 
interaction of x-rays with gold nanoparticles results in the 
generation of multiple low energy Auger electrons which usually 
short-lived species. The therapeutic efficacy of the radiation therapy 
heavily depends on the ratio of radiation dose to cancer cells to the 
dose imparted to normal tissues. Gold nanoparticles play an 
important role in enhancing the effective radiation dose to the 
diseased sites. In the presence of gold nanoparticles, in vitro studies 
have been performed to quantify the dose enhancement [70].  
The experimental results have shown that lower energy sources 
produced the highest effects. Interestingly, the dose enhancement 
from megavoltage irradiation was much higher than expected 
(>25%) due to the proximity of the nanoparticles to the cell nuclei. 
In few studies, application of gold nanoparticles in RT has been 
further expanded in small animals as well. Hainfield et al. have 
reported a significant anti-tumor effect with an overall increase in 
survival from 20% to 86% in case of mice receiving gold 
nanoparticle-assisted RT, versus RT alone, in a mammary carcinoma 
mouse model [71]. The mice were injected intravenously with 
2.7g/kg of 1.9 nm gold nanoparticles using 250 kVp x-rays. The 
results of the early theoretical and experimental studies have shown 
great potential for gold nanoparticle-aided radiation therapy to 
improve cancer treatments substantially. 
Photothermal therapy (PTT) 
Photothermal therapy (PTT) is a branch of light-induced thermal 
therapy in which electromagnetic near infrared (NIR) or infrared 
(IR) light is used for generating localized heating (up to 113 F) in the 
tumor tissues, with minimal invasiveness [72]. Thermal therapies 
cause necrosis of the cells through lysis and rupture of membranes 
and release of digestive enzymes. In addition, thermal therapeutic 
procedures are relatively simple to perform and therefore have the 
potential of improving recovery times, reducing complication rates 
and hospital stays.  
There have been many reports of different platforms of gold 
nanoparticles being used as photothermal sensitizers, which vary 
from spherical clusters of gold nanoparticles to gold nanorods, 
nanoshells, nanocages, etc [73-75]. The metallic gold nanoparticles 
are the strongest absorbers and their absorption coefficient, due to 
profound plasmon resonance, is at least three orders-of-magnitude 
greater when compared to other organic photosensitizers. The 
tunability of the gold surface plasmon peak to NIR region offers 
irradiation in the 700-900 nm spectral range which allows deeper 
penetration of the laser radiation into the biotissues. The basic 
principle for the use of gold nanoparticles in PTT relies on the 
absorption of the incident NIR or IR light by gold nanoparticles 
which results in the excitation of the free electrons at the surface of 
gold nanoparticles [76]. The excitation at the plasmon resonance 
frequency causes a coherent collective oscillation of the free 
electrons, and when there is an interaction between these excited 
electrons and the crystal lattice of the gold nanoparticles, the 
electrons relaxes, and the thermal energy is transferred to the 
lattice. Subsequently, the heat from the gold particles is dissipated 
into the surrounding environment. When this photo excitation is 
carried out in vivo at cancer sites, it leads to irreparable and 
localized damage in the tumor tissues. In the following section, we 
have categorized the various gold nano platform used for the PTT in 
various cancer models. 
Gold nanoshells 
Gold nanoshells are by far the most exploited nano platform for PTT 
applications, specifically in breast adenocarcinoma tumor models. 
The nanoshells are composed of a dielectric silica core covered with 
a thin metallic gold shell. The size of the nanoshells varies from 100-
300 nm. By tuning the relative dimensions of the core to the shell, 
the optical resonances can be turned over a wide range of 
wavelength, up to NIR region [7]. Also, the biocompatible gold 
nanoshell surface provides an ideal platform for chemical 
conjugation to various biomolecules for active targeting to the 
specific diseased sites and stealth polymers like PEG for enhanced 
circulation.  
The research groups of N. Halas and J. West at Rice University have a 
done a tremendous amount of work in using gold nanoshells as a 
potential candidate for the PTT. Hirsch et al. have shown that human 
breast carcinoma cells incubated with gold nanoshells, when 
exposed to NIR light, induced cell cytotoxicity due to the 
photothermal effect [77]. Also, they have shown the successful in 
vivo irreversible thermal tissue damage in the breast 
adenocarcinoma tumor mice model using NIR-absorbing, non-
bleaching nanoshells, monitored by real-time MR thermal imaging. 
The histological experiments with the damaged tissue sections 
confirmed the photothermal induced morbidity. Apart from these, 
Stern et al. have also reported tumor ablation by the NIR laser using 
PEGylated gold nanoshells injected intravenously into tumored mice 
[78]. The control mice group without the nanoshells injections 
showed a continued tumor growth as opposed to treated mice with 
no tumor for several months. Stern et al. have followed it up with a 
dose dependent study of the nanoshells in tumored animals [79]. 
They have shown that a slightly lower nanoshells dose (7 µl/g) only 
resulted in tumor growth arrest at 21 d, but not tumor ablation, 
which was otherwise observed with high dose (8.5 µl/g) with 93% 
tumor necrosis and regression. The reason why such a subtle 
difference in nanoshell dose could cause dramatically, different 
therapeutic efficacy deserves careful investigation. One explanation 
could be that most of these nanoshell-mediated PTT is based on the 
tumor accumulation of the nanoshells by passive uptake via the EPR 
effect. A careful investigation including the active targeting using the 
disease specific ligands and dose escalation studies would definitely 
provide insight for a better PTT efficiency.  
These demonstrations of the enormous potential of nanoshells in 
efficient tumor kill,coupled with the provision of real-time thermal 
MR monitoring of the therapeutic phase,paved the way for 
nanoshell-mediated PTT to knock the door of clinicians. In fact, 
Nanospectra Biosciences, which holds the license for medical use of 
Rice University’s nanoshell technology, began the first human 
clinical trial of nanoshell PTT in 2008. They have come up with the 
commercial name for the nanoshells as AuroLase® Therapy. The 
company is currently conducting a pilot study in patients with 
refractory head-and-neck cancer under an open Investigational 
Device Exemption (IDE), and plans to commence additional clinical 
studies in other cancers soon. 
Gold nanorods 
The absorption spectrum of gold nanorods can be easily tuned to the 
NIR region by changing their aspect ratio. One of the better-explored 
applications of nanorods is in the field of PTT. El-Sayed et al. have 
demonstrated the potential use of anti-EGFR targeted gold nanorods 
for selective photothermal therapy of cancer cells using a near-
infrared low-energy continuous-wave laser [80]. The use of pulsed 
laser mode provides the flexibility for localized cellular damage in 
case of individual metastatic or residual cells. Takahashi et al. have 
shown that by using the multi-pulse near-infrared lasers selective 
cell damage is achievable in cells treated with gold nanorods [81]. 
The effect of high energy lasers on nanorods and nanospheres has 
been studied to evaluate the PT properties of the nanorods before 
the nanorods disintegrate under the laser power. Goodrich et al. 
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have used shown a significant amount of nanorods accumulation in 
24 h in the murine colon carcinoma tumor after a systemic infusion 
of gold nanorods [82]. They concluded that the combination of 
nanorod dose and laser exposure level was sufficient for ablative 
effects in all treated animals and a complete ablation in>40% of the 
treated animals. However, further investigation of dose 
accumulations and laser dosimetry may lead to a highly effective 
therapy. In another report, Huang et al. have shown that appropriate 
surface modification of the CTAB coated gold nanorods with 
polyelectrolytes play an important role in stabilization of the optical 
response and in turn a reliable PT response [83].  
Gold spheres/clusters 
Spherical gold nanoparticles usually vary in size from few 
nanometers to 100 nm. A typical 13 nm citrate stabilized spherical 
nanoparticles show 520 nm plasmon peak, which lies in the visible 
range of the light spectrum. Zharov et al. have shown that since the 
absorbance wavelength of the small-sized nanoparticles lies in the 
visible range, which is suboptimal for in vivo applications, the 
assembly of gold nanoclusters on the cell membrane showed a 
significant increase in local absorption and red shifting. This led to 
higher cell morbidity, compared to the cells that did not have 
nanoclusters [84]. However, there have been reports in which 
small sized spherical gold nanoparticles have been used in PTT 
[85]. Recently, branched gold nanoparticles have been reported as 
potential PT agents because of large absorption cross section in 
the NIR window [86]. These branched nanoparticles were actively 
targeted with the antibody antigen-binding fragments against the 
HER2 antigen, which is overexpressed in breast and ovarian 
cancer cells.  
For PTT using gold-based nanoplatforms there have been two 
fundamental issues, (i) the local accumulation of the gold 
nanostructures in the target tissues should exceed a threshold 
concentration at which the nanostructures show an efficient thermal 
ablation, and (ii) the excitation light should be able to penetrate to 
deeper tissues. The first issue can be explored by an efficient active 
targeting with specific biomolecular ligands aimed at a particular 
disease, or by a localized delivery of the nanoparticles. However, an 
equal emphasis should be devoted for maximizing the tissue 
penetration of the excitation light, by optimizing the wavelength of 
light used, laser power, pulse sequences, etc., assisted with imaging 
modalities for real-time monitoring of the PTT efficacy. Improved 
fiber-optic based delivery of light in internal body locations is another 
avenue that can aid the advancement of PTT in the clinic. 
CONCLUSION 
In conclusion, it can be envisioned that the already rich applications 
of gold in medicine will further expand, with visible benefits towards 
the treatment of several diseases. Healthcare for the next century 
will heavily look forward towards the success of nanomedicine, with 
theranostics and personalized medicine being the visions to be 
realized. Facile surface chemistry and exquisite tunability of optical 
properties have led to the emergence of several bioconjugated gold 
nanoparticle-based bioanalytical assays for ultrasensitive, 
multiplexed and high-throughput detection of biomolecules. Also, 
owing to their both inherent and externally-incorporated diagnostic 
and therapeutic capabilities, gold nanostructures have already 
shown promise in theranostic medicine. In parallel, a key area the 
needs a thorough investigation would be the potential toxicity of 
gold nanostructures in humans, particularly when their long-term 
persistence in the body is a concern. A better understanding of the 
potential toxicity, dynamics, and route of expulsion from the body 
will portray a realistic picture of the promise of gold nanostructures 
in the human healthcare, thus clarifying several speculations that 
date back to ancient times.  
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